Viewing nowCombinationTelmisartan/Amlodipine Tablets 40/5mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Korea Union Pharmaceutical Co., Ltd.

MFDS item code 201606804 · Approved 2016.11.29 · Insurance code 665506890
Treatment of essential hypertension not controlled with monotherapy
This medication is used to more effectively control blood pressure in patients with essential hypertension when blood pressure is not sufficiently controlled with monotherapy of amlodipine or telmisartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ○ Older adults: In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters; therefore, it should not be taken by women who are pregnant or may become pregnant. If pregnancy is confirmed, discontinue use immediately and switch to another safe treatment method. This medication should also not be administered to patients with certain medical conditions, such as liver impairment, biliary obstruction, severe aortic stenosis, in shock status, or those with diabetes or moderate to severe renal impairment. Patients with primary aldosteronism, heart valve diseases, impaired liver function, gastrointestinal disorders, renovascular hypertension, hypotension, dialysis-requiring renal failure, and elderly patients should use this medication with caution. Common side effects while taking this medication include dizziness or peripheral edema, so caution is needed. Rarely, symptoms such as irregular heartbeat, liver dysfunction, skin rash, myalgia, and renal dysfunction may occur. This medication may interact with other drugs; therefore, especially when taken with digoxin, lithium, warfarin, non-steroidal anti-inflammatory drugs, consultation with a healthcare professional is essential. Due to the risk of hyperkalemia, it is important to regularly check potassium levels in the blood. Women who are breastfeeding are advised not to take this medication, and safety data in pediatric patients is insufficient, so it is not recommended. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, and immediate medical assistance should be sought. This medication should be stored out of reach of children and kept in its original packaging.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a light-protective and tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.
White and pale gray, double convex oval tablet
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Korea Union Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.